title: Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.
abstract: Despite significant improvements in our understanding of Crohn's disease (CD) and ulcerative colitis (UC) in recent years, questions remain regarding the best approaches to assessment and management of these chronic diseases during periods of both relapse and remission. Various serologic biomarkers have been used in the evaluation of patients with both suspected and documented inflammatory bowel disease (IBD), and while each has potential utility in the assessment of patients with IBD, potential limitation remain with each method of assessment. Given these potential shortcomings, there has been increased interest in other means of evaluation of patients with IBD, including an expanding interest in the role of gene expression profiling. Among patients with IBD, gene expression profiles obtained from whole blood have been used to differentiate active from inactive CD, as well as to differentiate between CD, UC, and non-inflammatory diarrheal conditions. There are many opportunities for a non-invasive, blood based test to aid in the assessment of patients with IBD, particularly when considering more invasive means of evaluation including endoscopy with biopsy. Furthermore, as the emphasis on personalized medicine continues to increase, the potential ability of gene expression analysis to predict patient response to individual therapies offers great promise. While whole blood gene expression analysis may not completely replace more traditional means of evaluating patients with suspected or known IBD, it does offer significant potential to expand our knowledge of the underlying genes involved in the development of these diseases.
authors.affiliation: Edward L Barnes, Robert Burakoff, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.
authors.forename: Edward L
authors.initials: EL
authors.lastname: Barnes
authors.affiliation: Edward L Barnes, Robert Burakoff, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.
authors.forename: Choong-Chin
authors.initials: CC
authors.lastname: Liew
authors.affiliation: Edward L Barnes, Robert Burakoff, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.
authors.forename: Samuel
authors.initials: S
authors.lastname: Chao
authors.affiliation: Edward L Barnes, Robert Burakoff, Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA 02115, United States.
authors.forename: Robert
authors.initials: R
authors.lastname: Burakoff
keywords: Biomarkers; Crohn’s disease; Gene expression analysis; Gene profiling; Inflammatory bowel disease; Ulcerative colitis; Whole blood gene expression analysis